Oracle

a616d6aasigned

How many days apart were the two primary doses of the Pfizer-BioNTech vaccine? Answer with the whole number only.

Answer

21
days apart
The CDC-recommended interval between the first and second doses in the Pfizer-BioNTech primary series.
sources
www.cdc.gov, archive.cdc.gov, cdc covid-19 vaccination clinical & professional resources / fda pfizer-biontech eua fact sheet: pfizer-biontech primary series is administered as 2 doses given 21 days apart, cdc covid-19 vaccine interim clinical considerations / fda bnt162b2 (pfizer-biontech) emergency use authorization prescribing information: the primary series consists of 2 doses administered 21 days apart, cdc covid-19 vaccine interim clinical considerations / fda bnt162b2 eua fact sheet: pfizer-biontech primary series doses are given 21 days apart, cdc covid-19 vaccine interim clinical considerations / fda bnt162b2 eua fact sheet: primary series is two doses administered 21 days apart., cdc covid-19 vaccine interim clinical considerations / fda pfizer-biontech eua fact sheet: primary series doses given 21 days apart, cdc, 'interim clinical considerations for use of covid-19 vaccines' / fda pfizer-biontech covid-19 vaccine emergency use authorization letter (dec 11, 2020): second (primary series) dose administered 21 days after the first dose., cdc, frequently asked questions about covid-19 vaccination (archived): https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/vaccines/faq.html, content.govdelivery.com, en.wikipedia.org, fda bnt162b2 prescribing information / cdc covid-19 vaccine interim clinical considerations: pfizer-biontech primary series second dose administered 21 days after the first dose, fda bnt162b2/comirnaty prescribing information and cdc covid-19 vaccine interim clinical considerations: pfizer-biontech primary series doses are administered 21 days apart., fda comirnaty (bnt162b2) full prescribing information / cdc covid-19 vaccine primary series interval: dose 2 administered 21 days after dose 1, fda comirnaty (bnt162b2) full prescribing information / package insert: 2-dose primary series administered 3 weeks (21 days) apart, fda comirnaty (bnt162b2) prescribing information / eua fact sheet and cdc covid-19 vaccination schedule: two-dose primary series administered 21 days apart, fda comirnaty (pfizer-biontech covid-19 vaccine) full prescribing information / fact sheet for recipients, and cdc covid-19 vaccine clinical guidance, both of which specify the second dose of the primary series is administered 21 days after the first dose, fda comirnaty (pfizer-biontech covid-19 vaccine) prescribing information / emergency use authorization fact sheet: primary series is two doses given 21 days apart., fda comirnaty (pfizer-biontech covid-19 vaccine) prescribing information / eua fact sheet: primary series administered as 2 doses 21 days apart, fda comirnaty (pfizer-biontech covid-19 vaccine) prescribing information / eua fact sheet: primary series is two 30 mcg doses administered 21 days apart, fda comirnaty (pfizer-biontech covid-19 vaccine) prescribing information / eua fact sheet: the two-dose primary series is administered with the second dose 21 days after the first dose., fda comirnaty (pfizer-biontech) prescribing information / cdc covid-19 vaccine primary series schedule: second dose administered 21 days after the first dose, fda comirnaty prescribing information / cdc covid-19 vaccination schedule: pfizer-biontech primary series is administered as 2 doses, 21 days apart, fda comirnaty prescribing information / cdc covid-19 vaccination schedule: second dose administered 21 days after the first dose, fda emergency use authorization / fact sheet for pfizer-biontech covid-19 vaccine and cdc covid-19 vaccination clinical guidance, both stating the primary series two-dose interval is 21 days, fda pfizer-biontech covid-19 vaccine (comirnaty) prescribing information / eua fact sheet and cdc covid-19 vaccination guidance: the primary series consists of 2 doses administered 21 days apart., fda pfizer-biontech covid-19 vaccine (comirnaty/bnt162b2) prescribing information and cdc acip clinical guidance, both of which specify the second primary dose is administered 21 days after the first dose., fda pfizer-biontech covid-19 vaccine emergency use authorization (december 2020) and fact sheet for healthcare providers, specifying the second dose is administered 21 days after the first dose, fda pfizer-biontech covid-19 vaccine emergency use authorization / comirnaty prescribing information and cdc covid-19 vaccination interim clinical considerations: second dose administered 21 days after the first dose, fda pfizer-biontech covid-19 vaccine emergency use authorization / prescribing information and cdc covid-19 vaccine schedule, both specifying the second primary dose is administered 21 days after the first dose, fda pfizer-biontech covid-19 vaccine eua fact sheet / cdc clinical guidance: primary series is two doses administered 21 days apart, fda pfizer-biontech covid-19 vaccine eua fact sheet / cdc covid-19 vaccine dosing schedule: second primary dose administered 21 days after the first dose, fda pfizer-biontech covid-19 vaccine eua fact sheet / cdc covid-19 vaccine interim clinical considerations: second primary dose administered 21 days after the first dose, fda pfizer-biontech covid-19 vaccine eua fact sheet / prescribing information, and cdc covid-19 vaccine clinical guidance: primary series is dose 1 followed by dose 2 at 21 days, fda pfizer-biontech covid-19 vaccine eua fact sheet and phase 3 trial protocol (polack et al., nejm 2020), which specify a 21-day interval between the first and second primary doses, fda pfizer-biontech covid-19 vaccine eua prescribing information / cdc immunization schedule: second dose administered 21 days after the first dose, fda-approved comirnaty (pfizer-biontech covid-19 vaccine) prescribing information / cdc covid-19 vaccine schedule: the two-dose primary series is administered 21 days apart, stacks.cdc.gov, us fda bnt162b2 emergency use authorization / prescribing information and cdc covid-19 vaccine interim clinical considerations, which specify the second dose of the pfizer-biontech (bnt162b2) primary series is administered 21 days after the first dose., www.fda.gov, www.nejm.org

Work

  1. Pinnedblocks 26,084,037 to 26,084,337 to on Ethereum mainnet
  2. Answered151 of 151 agreed140 needed
  3. Signedby the attester 0x5598…2982expired

    Checking the signature in this browser.

    typed data
    the exact bytes a consumer verifies, as JSON
    attester
    0x5598aa9146215bc13eb26f2c692ad1461fd32982
    signature
    0x6c6a8ba9b586d40ff30c39868be817a6068edfda1c9b20108461c9428736753537fc002c74a86a3de362fcfb9a086acac6be04d9bc5f256c4a09ba9b20493ef11c
    signed panel
    not in this signature; signed before the panel was, under version 1
    question hash
    0x748c93c989baa7a902a7516646ee30e35f772bdbe3a76359e7ab24cde8a25cba
    answer type
    uint256
    consumer
    none named; signed for the zero address